Brief: Ose Immunotherapeutics Receives EUR 10 Mln Payment Corresponding To Second Tranche Of EIB Financing

Ose Immunotherapeutics SA

16/12/2022 17:26

Dec 16 (Reuters) - Ose Immunotherapeutics Sa  OSE.PA :
    * OSE IMMUNOTHERAPEUTICS RECEIVES A €10 MILLION PAYMENT
CORRESPONDING TO THE SECOND TRANCHE OF THE FINANCING GRANTED BY
THE EUROPEAN INVESTMENT BANK
    * ANNOUNCED TODAY A €10 MILLION DRAWDOWN CORRESPONDING TO
THE
SECOND TRANCHE OF THE FINANCING GRANTED BY THE EUROPEAN
INVESTMENT BANK (EIB)
    * WISHES TO REINFORCE ITS FINANCIAL POSITION UNTIL Q3 2023
BY
DRAWING ON THE SECOND TRANCHE OF THE FACILITY, TO FINANCE ITS
PRECLINICAL AND CLINICAL PROGRAMS.
    * THIS SECOND TRANCHE WILL CARRY A FIXED INTEREST OF 5% PER
YEAR
PAID ANNUALLY, WITH A MATURITY OF FIVE YEARS.
    * THE SUBSCRIPTION PRICE IS €0.01 PER WARRANT, I.E., €5,500
    * WARRANTS WILL ONLY BE EXERCISABLE FROM 16 DECEMBER 2027

Source text for Eikon:  ID:nBw6rx7rPa 
Further company coverage:  OSE.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))